Autisms

Neural Circuit Development and Function in the Heathy and Diseased Brain

Volumn , Issue , 2013, Pages 651-694

  Persico, A M ^a,b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882607698     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397267-5.00045-5     Document Type: Chapter

References (501)

1. Abrahams B.S., Geschwind D.H. Advances in autism genetics: On the threshold of a new neurobiology. Nature Reviews Genetics 2008, 9:341-355.
2. Abrahams B.S., Tentler D., Perederiy J.V., Oldham M.C., Coppola G., Geschwind D.H. Genome-wide analyses of human perisylvian cerebral cortical patterning. Proceedings of the National Academy of Science of the United States of America 2007, 104:17849-17854.
3. Abramson R.K., Wright H.H., Carpenter R., et al. Elevated blood serotonin in autistic probands and their first-degree relatives. Journal of Autism and Developmental Disorders 1989, 19:397-407.
4. Adolphs R., Spezio M.L., Parlier M., Piven J. Distinct face-processing strategies in parents of autistic children. Current Biology 2008, 18:1090-1093.
5. Ahmed Z., Babaei S., Maguire G.F., et al. Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine. Cardiovascular Research 2003, 57:225-231.
6. Aït Yahya-Graison E., Aubert J., Dauphinot L., et al. Classification of human chromosome 21 gene-expression variations in Down syndrome: Impact on disease phenotypes. American Journal of Human Genetics 2007, 81:475-491.
7. Alarcón M., Abrahams B.S., Stone J.L., et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. American Journal of Human Genetics 2008, 82:150-159.
8. Allgayer H. Regulation and clinical significance of urokinase-receptor (u-PAR), an invasion-related molecule. Gastroenterology 2006, 44:503-511.
9. Allison A.C. Genetic control of resistance to human malaria. Current Opinion in Immunology 2009, 21:499-505.
10. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4th edn.
11. American Psychiatric Association (accessed September 2011). http://www.dsm5.org/Pages/Default.aspx.
12. American Psychiatric Association DSM-5 development Available at, (accessed October 2012). http://www.dsm5.org/Pages/Default.aspx.
13. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics 1999, 23:185-188.
14. Anderson G.M., Gutknecht L., Cohen D.J., et al. Serotonin transporter promoter variants in autism: Functional effects and relationship to platelet hyperserotonemia. Molecular Psychiatry 2002, 7:831-836.
15. Arking D.E., Cutler D.J., Brune C.W., et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. American Journal of Human Genetics 2008, 82:160-164.
16. Ashley-Koch A.E., Mei H., Jaworski J., et al. An analysis paradigm for investigating multi-locus effects in complex disease: Examination of three GABA receptor subunit genes on 15q11-q13 as risk factors for autistic disorder. Annals of Human Genetics 2006, 70:281-292.
17. Ashwood P., Wills S., Van de Water J. The immune response in autism: A new frontier for autism research. Journal of Leukocyte Biology 2006, 80:1-15.
18. Asperger H. Die 'Autistischen Psychopathen' im Kindesalter. Archiv fur Psychiatrie und Nervenkrankheiten 1944, 117:76-136.
19. Asperger H. Autistic Psychopathy in Childhood. Translated from Frith U (1991) Autism and Asperger's Syndrome 1944, Cambridge University Press, Cambridge, UK.
20. Autism Genome Project Consortium Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics 2007, 39:319-328.
21. Bakkaloglu B., O'Roak B.J., Louvi A., et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. American Journal of Human Genetics 2008, 82:165-173.
22. Banatvala J.E., Brown D.W. Rubella. Lancet 2004, 363:1127-1137.
23. Bandim J.M., Ventura L.O., Miller M.T., Almeida H.C., Costa A.E. Autism and Möbius sequence: An exploratory study of children in northeastern Brazil. Arquivos de Neuro-Psiquiatria 2003, 61:181-185.
24. Bauman M.L., Kemper T.L. Neuroanatomic observations of the brain in autism: A review and future directions. International Journal of Developmental Neuroscience 2005, 23:183-187.
25. Beilman M., Vande Woude G.F., Dienes H.P., Schirmacher P. Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood 2000, 95:3964-3969.
26. Belmonte M.K., Gomot M., Baron-Cohen S. Visual attention in autism families: 'Unaffected' sibs share atypical frontal activation. Journal of Child Psychology and Psychiatry 2010, 51:259-276.
27. Benayed R., Choi J., Matteson P.G., et al. Autism-associated haplotype affects the regulation of the homeobox gene, ENGRAILED 2. Biological Psychiatry 2009, 66:911-917.
28. Benayed R., Gharani N., Rossman I., et al. Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. American Journal of Human Genetics 2005, 77:851-868.
29. Benvenuto A., Moavero R., Alessandrelli R., Manzi B., Curatolo P. Syndromic autism: Causes and pathogenetic pathways. World Journal of Pediatrics 2009, 5:169-176.
30. Berger B.E., Navar-Boggan A.M., Omer S.B. Congenital rubella syndrome and autism spectrum disorder prevented by rubella vaccination-United States, 2001-2010. BMC Public Health 2010, 11:340.
31. Betancur C., Corbex M., Spielewoy C., et al. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Molecular Psychiatry 2002, 7:67-71.
32. Betancur C., Sakurai T., Buxbaum J.D. The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends in Neurosciences 2009, 32:402-412.
33. Beyer K.S., Blasi F., Bacchelli E., et al. Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Human Genetics 2002, 111:305-309.
34. Bigler E.D., Abildskov T.J., Petrie J.A., et al. Volumetric and voxel-based morphometry findings in autism subjects with and without macrocephaly. Developmental Neuropsychology 2010, 35:278-295.
35. Blatt G.J., Fitzgerald C.M., Guptill J.T., Booker A.B., Kemper T.L., Bauman M.L. Density and distribution of hippocampal neurotransmitter receptors in autism: An autoradiographic study. Journal of Autism and Developmental Disorders 2001, 31:537-543.
36. Bleuler E. Dementia Praecox oder Gruppe der Schizophrenien. Handbuch der Psychiatrie 1911, Deuticke, Leipzig. G. Aschaffenburg (Ed.).
37. Boccone L., Dessì V., Zappu A., et al. Bannayan-Riley-Ruvalcaba syndrome with reactive nodular lymphoid hyperplasia and autism and a PTEN mutation. American Journal of Medical Genetics Part A 2006, 140A:1965-1969.
38. Boddaert N., Belin P., Chabane N., et al. Perception of complex sounds: Abnormal pattern of cortical activation in autism. The American Journal of Psychiatry 2003, 160:2057-2060.
39. Boddaert N., Zilbovicius M., Philipe A., et al. MRI findings in 77 children with non-syndromic autistic disorder. PLoS One 2009, 4:e4415.
40. Bonnel A., McAdams S., Smith B., et al. Enhanced pure-tone pitch discrimination among persons with autism but not Asperger syndrome. Neuropsychologia 2010, 48:2465-2475.
41. Bonora E., Beyer K.S., Lamb J.A., et al. Analysis of reelin as a candidate gene for autism. Molecular Psychiatry 2003, 8:885-892.
42. Bosley T.M., Salih M.A., Alorainy I.A., et al. Clinical characterization of the HOXA1 syndrome BSAS variant. Neurology 2007, 69:1245-1253.
43. Bosley T.M., Alorainy I.A., Salih M.A., et al. The clinical spectrum of homozygous HOXA1 mutations. American Journal of Medical Genetics Part A 2008, 146A:1235-1240.
44. Briegel W., Schimek M., Kamp-Becker I., Hofmann C., Schwab K.O. Autism spectrum disorders in children and adolescents with Moebius sequence. European Child and Adolescent Psychiatry 2009, 18:515-519.
45. Brune C.W., Korvatska E., Allen-Brady K., et al. Heterogeneous association between engrailed-2 and autism in the CPEA network. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2008, 147B:187-193.
46. Bruneau N., Bonnet-Brilhault F., Gomot M., Adrien J.L., Barthélémy C. Cortical auditory processing and communication in children with autism: Electrophysiological/behavioral relations. International Journal of Psychophysiology 2003, 51:17-25.
47. Bucan M., Abrahams B.S., Wang K., et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genetics 2009, 5:e1000536.
48. Buie T., Campbell D.B., Fuchs G.J., et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: A consensus report. Pediatrics 2010, 125:S1-S18.
49. Butler M.G., Dasouki M.J., Zhou X.P., et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Journal of Medical Genetics 2005, 42:318-321.
50. Buxbaum J.D. Multiple rare variants in the etiology of autism spectrum disorders. Dialogues in Clinical Neurosciences 2009, 11:35-43.
51. Buxbaum J.D., Silverman J.M., Smith C.J., et al. Association between a GABRB3 polymorphism and autism. Molecular Psychiatry 2002, 7:311-316.
52. Buxbaum J.D., Cai G., Chaste P., et al. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2007, 144B:484-491.
53. Cacciotti P., Libener R., Betta P., et al. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma. Proceedings of the National Academy of Science of the United States of America 2001, 98:12032-12037.
54. Cameron B., Landreth G.E. Inflammation, microglia, and Alzheimer's disease. Neurobiology of Disease 2010, 37:503-509.
55. Campbell D.B., Sutcliffe J.S., Ebert P.J., et al. A genetic variant that disrupts MET transcription is associated with autism. Proceedings of the National Academy of Science of the United States of America 2006, 103:16834-16839.
56. Campbell D.B., D'Oronzio R., Garbett K., et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Annals of Neurology 2007, 62:243-250.
57. Campbell D.B., Li C., Sutcliffe J.S., Persico A.M., Levitt P. Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Research 2008, 1:159-168.
58. Campbell D.B., Buie T.M., Winter H., et al. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics 2009, 123:1018-1024.
59. Campbell D.B., Warren D., Sutcliffe J.S., Lee E.B., Levitt P. Association of MET with social and communication phenotypes in individuals with autism spectrum disorder. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2010, 153B:438-446.
60. Cantor R.M., Kono N., Duvall J.A., et al. Replication of autism linkage: Fine-mapping peak at 17q21. American Journal of Human Genetics 2005, 76:1050-1056.
61. Canu E., Boccardi M., Ghidoni R., et al. HOXA1 A218G polymorphism is associated with smaller cerebellar volume in healthy humans. Journal of Neuroimaging 2009, 19:353-358.
62. Carayol J., Schellenberg G.D., Tores F., Hager J., Ziegler A., Dawson G. Assessing the impact of a combined analysis of four common low-risk genetic variants on autism risk. Molecular Autism 2010, 1:4.
63. Carneiro A.M., Cook E.H., Murphy D.L., Blakely R.D. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. Journal of Clinical Investigation 2008, 118:1544-1552.
64. Carney R.M., Wolpert C.M., Ravan S.A., et al. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatric Neurology 2003, 28:205-211.
65. Carter C.S. Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders?. Behavioral Brain Research 2007, 176:170-186.
66. Carter C.S., Grippo A.J., Pournajafi-Nazarloo H., Ruscio M.G., Porges S.W. Oxytocin, vasopressin and sociality. Progress in Brain Research 2008, 170:331-336.
67. Carvalho C.M., Zhang F., Lupski J.R. Evolution in health and medicine Sackler colloquium: Genomic disorders: A window into human gene and genome evolution. Proceedings of the National Academy of Science of the United States of America 2010, 107(supplement 1):1765-1771.
68. Cattaneo L., Fabbri-Destro M., Boria S., et al. Impairment of actions chains in autism and its possible role in intention understanding. Proceedings of the National Academy of Science of the United States of America 2007, 104:17825-17830.
69. Chadman K.K., Gong S., Scattoni M.L., et al. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Research 2008, 1:147-158.
70. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: From clinic to neurobiology. Neuron 2007, 56:422-437.
71. Chauhan A., Chauhan V. Oxidative stress in autism. Pathophysiology 2006, 13:171-181.
72. Cheh M.A., Millonig J.H., Roselli L.M., et al. En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Research 2006, 1116:166-176.
73. Chess S. Autism in children with congenital rubella. Journal of Autism & Childhood Schizophrenia 1971, 1:33-47.
74. Chess S. Follow-up report on autism in congenital rubella. Journal of Autism & Childhood Schizophrenia 1977, 7:69-81.
75. Chess S., Fernandez P., Korn S. Behavioral consequences of congenital rubella. Journal of Pediatrics 1978, 93:699-703.
76. Chih B., Afridi S.K., Clark L., Scheiffele P. Disorder-associated mutations lead to functional inactivation of neuroligins. Human Molecular Genetics 2004, 13:1471-1477.
77. Ching M.S., Shen Y., Tan W.H., et al. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2010, 153B:937-994.
78. Chisaka O., Musci T.S., Capecchi M.R. Developmental defects of the ear, cranial nerves, and hindbrain resulting from targeted disruption of the mouse homeobox gene Hox-1.6. Nature 1992, 355:516-520.
79. Chiu P.H., Kayali M.A., Kishida K.T., et al. Self responses along cingulate cortex reveal quantitative neural phenotype for high-functioning autism. Neuron 2008, 57:463-473.
80. Christian S.L., Brune C.W., Sudi J., et al. Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biological Psychiatry 2008, 63:1111-1117.
81. Christianson A.L., Chesler N., Kromberg J.G. Fetal valproate syndrome: Clinical and neuro-developmental features in two sibling pairs. Developmental Medicine & Child Neurology 1994, 36:361-369.
82. Chubykin A.A., Liu X., Comoletti D., Tsigelny I., Taylor P., Südhof T.C. Dissection of synapse induction by neuroligins: Effect of a neuroligin mutation associated with autism. Journal of Biological Chemistry 2005, 280:22365-22374.
83. Cohen D., Pichard N., Tordjman S., et al. Specific genetic disorders and autism: Clinical contribution towards their identification. Journal of Autism and Developmental Disorders 2005, 35:103-116.
84. Comi A.M., Zimmerman A.W., Frye V.H., Law P.A., Peeden J.N. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Journal of Child Neurology 1999, 14:388-394.
85. Comoletti D., De Jaco A., Jennings L.L., et al. The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing. The Journal of Neuroscience 2004, 24:4889-4893.
86. Conciatori M., Stodgell C.J., Hyman S.L., et al. Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biological Psychiatry 2004, 55:413-419.
87. Cook E.H., Leventhal B.L., Heller W., Metz J., Wainwright M., Freedman D.X. Autistic children and their first-degree relatives: Relationships between serotonin and norepinephrine levels and intelligence. The Journal of Neuropsychiatry & Clinical Neuroscience 1990, 2:268-274.
88. Cook E.H., Courchesne R.Y., Cox N.J., et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. American Journal of Human Genetics 1998, 62:1077-1083.
89. Cook E.H., Leventhal B.L., Freedman D.X. Free serotonin in plasma: Autistic children and their first-degree relatives. Biological Psychiatry 1988, 24:488-491.
90. Courchesne E. Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Current Opinion in Neurobiology 1997, 7:269-278.
91. Courchesne E., Pierce K. Why the frontal cortex in autism might be talking only to itself: Local over-connectivity but long-distance disconnection. Current Opinions in Neurobiology 2005, 15:225-230.
92. Courchesne E., Pierce K., Schumann C.M., et al. Mapping early brain development in autism. Neuron 2007, 56:399-413.
93. Coutinho A.M., Oliveira G., Katz C., et al. MECP2 coding sequence and 3'UTR variation in 172 unrelated autistic patients. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2007, 144B:475-483.
94. Coutinho A.M., Oliveira G., Morgadinho T., et al. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Molecular Psychiatry 2004, 9:264-271.
95. Coutinho A.M., Sousa I., Martins M., et al. Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Human Genetics 2007, 121:243-256.
96. Craig A.M., Kang Y. Neurexin-neuroligin signaling in synapse development. Current Opinion in Neurobiology 2007, 17:43-52.
97. Cross S., Kim S.J., Weiss L.A., et al. Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology 2008, 33:353-360.
98. Curran S., Roberts S., Thomas S., et al. An association analysis of microsatellite markers across the Prader-Willi/Angelman critical region on chromosome 15 (q11-13) and autism spectrum disorder. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2005, 137B:25-28.
99. D'Amelio M., Ricci I., Sacco R., et al. Paraoxonase gene variants are associated with autism in North America, but not in Italy: Possible regional specificity in gene-environment interactions. Molecular Psychiatry 2005, 10:1006-1016.
100. D'Arcangelo G., Miao G.G., Chen S.C., Soares H.D., Morgan J.I., Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995, 374:719-723.
101. D'Arcangelo G., Homayouni R., Keshvara L., Rice D.S., Sheldon M., Curran T. Reelin is a ligand for lipoprotein receptors. Neuron 1999, 24:471-479.
102. Daoud H., Bonnet-Brilhault F., Védrine S., et al. Autism and nonsyndromic mental retardation associated with a de novo mutation in the NLGN4X gene promoter causing an increased expression level. Biological Psychiatry 2009, 66:906-910.
103. Dapretto M., Davies M.S., Pfeifer J.H., et al. Understanding emotions in others: Mirror neuron dysfunction in children with autism spectrum disorders. Nature Neuroscience 2006, 9:28-30.
104. Davis C.A., Noble-Topham S.E., Rossant J., Joyner A.L. Expression of the homeobox-containing gene En-2 delineates a specific region of the developing mouse brain. Genes and Development 1998, 2:361-371.
105. Dawson G., Rogers S., Munson J., et al. Randomized, controlled trial of an intervention for toddlers with autism: The Early Start Denver Model. Pediatrics 2010, 125:e17-e23.
106. Dean C., Scholl F.G., Choih J., et al. Neurexin mediates the assembly of presynaptic terminals. Nature Neuroscience 2003, 6:708-716.
107. Delahanty R.J., Kang J.Q., Brune C.W., et al. Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism. Molecular Psychiatry 2011, 16:86-96.
108. DeLorey T.M., Sahbaie P., Hashemi E., Homanics G.E., Clark J.D. Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: A potential model of autism spectrum disorder. Behavioral Brain Research 2008, 187:207-220.
109. Delorme R., Goussé V., Roy I., et al. Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive-compulsive disorder. European Psychiatry 2007, 22:32-38.
110. Devlin B., Bennett P., Dawson G., et al. Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA network. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2004, 126:46-50.
111. Dhar S.U., del Gaudio D., German J.R., et al. 22q13.3 deletion syndrome: Clinical and molecular analysis using array CGH. American Journal of Medical Genetics part A 2010, 152A:573-581.
112. Di Pino G., Moessner R., Lesch K.P., Lauder J.M., Persico A.M. Roles for serotonin in neurodevelopment: More than just neural transmission. Current Neuropharmacology 2004, 2:403-418.
113. DiCicco-Bloom E., Lord C., Zwaigenbaum L., et al. The developmental neurobiology of autism spectrum disorder. The Journal of Neuroscience 2006, 26:6897-6906.
114. Dissanayake C., Bui Q.M., Huggins R., Loesch D.Z. Growth in stature and head circumference in high-functioning autism and Asperger disorder during the first 3 years of life. Developmental Psychopathology 2006, 18:381-393.
115. Doetschman T. Influence of genetic background on genetically engineered mouse phenotypes. Methods in Molecular Biology 2009, 530:423-433.
116. Dölen G., Osterweil E., Rao B.S., et al. Correction of fragile X syndrome in mice. Neuron 2007, 56:955-962.
117. Dong E., Guidotti A., Grayson D.R., Costa E. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proceedings of the National Academy of Science of the United States of America 2007, 104:4676-4681.
118. D'Souza A., Onem E., Patel P., La Gamma E.F., Nankova B.B. Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation. Brain Research 2009, 1247:1-10.
119. Durand C.M., Betancur C., Boeckers T.M., et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics 2007, 39:25-27.
120. Durand C.M., Perroy J., Loll F., et al. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Molecular Psychiatry 2011, 17:71-84.
121. Dutta S., Guhathakurta S., Sinha S., et al. Reelin gene polymorphisms in the Indian population: A possible paternal 5'UTR-CGG-repeat-allele effect on autism. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2007, 144B:106-112.
122. Dutta S., Sinha S., Ghosh S., Chatterjee A., Ahmed S., Usha R. Genetic analysis of reelin gene (RELN) SNPs: No association with autism spectrum disorder in the Indian population. Neuroscience Letters 2008, 441:56-60.
123. Duvall J.A., Lu A., Cantor R.M., Todd R.D., Constantino J.N., Geschwind D.H. A quantitative trait locus analysis of social responsiveness in multiplex autism families. American Journal of Psychiatry 2007, 164:656-662.
124. Ebstein R.P., Israel S., Lerer E., et al. Arginine vasopressin and oxytocin modulate human social behavior. Annals of the New York Academy of Science 2009, 1167:87-102.
125. Elia J., Gai X., Xie H.M., et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Molecular Psychiatry 2010, 15:637-646.
126. Elsen G.E., Choi L.Y., Prince V.E., Ho R.K. The autism susceptibility gene met regulates zebrafish cerebellar development and facial motor neuron migration. Developmental Biology 2009, 335:78-92.
127. Eng C. PTEN: One gene, many syndromes. Human Mutation 2003, 22:183-198.
128. Engel S.M., Berkowitz G.S., Barr D.B., et al. Prenatal organophosphate metabolite and organochlorine levels and performance on the Brazelton Neonatal Behavioral Assessment Scale in a multiethnic pregnancy cohort. American Journal of Epidemiology 2007, 165:1397-1404.
129. Englert Y., Lesage B., Van Vooren J.P., et al. Medically assisted reproduction in the presence of chronic viral diseases. Human Reproduction Update 2004, 10:149-162.
130. Engman M.L., Lewensohn-Fuchs I., Mosskin M., Malm G. Congenital cytomegalovirus infection; the impact of cerebral cortical malformations. Acta Paediatrica 2010, 99:1344-1349.
131. Eskenazi B., Rosas L.G., Marks A.R., et al. Pesticide toxicity and the developing brain. Basic and Clinical Pharmacology & Toxicology 2008, 102:228-236.
132. Etherton M.R., Blaiss C.A., Powell C.M., Südhof T.C. Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proceedings of the National Academy of Science of the United States ofAmerica 2009, 106:17998-18003.
133. Etherton M., Földy C., Sharma M., et al. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proceedings of the National Academy of Science of the United States ofAmerica 2011, 108:13764-13769.
134. Etherton M.R., Tabuchi K., Sharma M., Ko J., Südhof T.C. An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus. EMBO Journal 2011, 30:2908-2919.
135. Fatemi S.H., Stary J.M., Egan E.A. Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Cellular and Molecular Neurobiology 2002, 22:139-152.
136. Fatemi S.H., Snow A.V., Stary J.M., et al. Reelin signaling is impaired in autism. Biological Psychiatry 2005, 57:777-787.
137. Fatemi S.H., Reutiman T.J., Folsom T.D., Thuras P.D. GABA(A) receptor downregulation in brains of subjects with autism. Journal of Autism and Developmental Disorders 2009, 39:223-230.
138. Feinstein C., Singh S. Social phenotypes in neurogenetic syndromes. Child & Adolescent Psychiatric Clinics of North America 2007, 16:631-647.
139. Feng J., Schroer R., Yan J., et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neuroscience Letters 2006, 409:10-13.
140. Ferguson J.N., Young L.J., Hearn E.F., Matzuk M.M., Insel T.R., Winslow J.T. Social amnesia in mice lacking the oxytocin gene. Nature Genetics 2000, 25:284-288.
141. Fernandez B.A., Roberts W., Chung B., et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. Journal of Medical Genetics 2010, 47:195-203.
142. Ferré N., Marsillach J., Camps J., et al. Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection. Clinica Chimica Acta 2005, 361:206-210.
143. Fillano J., Goldenthal M.J., Rhodes C.H., Marín-García J. Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. Journal of Child Neurology 2002, 17:435-439.
144. Flatscher-Bader T., Foldi C.J., Chong S., et al. Increased de novo copy number variants in the offspring of older males. Translational Psychiatry 2011, 1:e34.
145. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. The Journal of Clinical Psychiatry 2005, 66(supplement 10):3-8.
146. Fombonne E., Rogé B., Claverie J., Courty S., Frémolle J. Microcephaly and macrocephaly in autism. Journal of Autism and Developmental Disorders 1999, 29:113-119.
147. Freitag C.M. The genetics of autistic disorders and its clinical relevance: A review of the literature. Molecular Psychiatry 2007, 12:2-22.
148. Frisque R.J., Hofstetter C., Tyagarajan S.K. Transforming activities of JC virus early proteins. Advances in Experimental Medicine and Biology 2006, 577:288-309. Eureka.com/Landes Bioscience, Georgetown, TX. N. Ahsan (Ed.).
149. Furman D.J., Chen M.C., Gotlib I.H. Variant in oxytocin receptor gene is associated with amygdala volume. Psychoneuroendocrinology 2011, 36:891-897.
150. Gaita L., Manzi B., Sacco R., et al. Decreased serum arylesterase activity in autism spectrum disorders. Psychiatry Research 2010, 180:105-113.
151. Gallagher L., Hawi Z., Kearney G., Fitzgerald M., Gill M. No association between allelic variants of HOXA1/HOXB1 and autism. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2004, 124B:64-67.
152. Garbett K., Ebert P.J., Mitchell A., et al. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiology of Disease 2008, 30:303-311.
153. Gauthier J., Spiegelman D., Piton A., et al. Novel de novo SHANK3 mitation in autistic patients. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2009, 150B:421-424.
154. Gauthier J., Champagne N., Lafrenière R.G., et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proceedings of the National Academy of Science of the United States of America 2010, 107:7863-7868.
155. Geschwind D.H. Genetics of autism spectrum disorders. Trends in Cognitive Sciences 2011, 15:409-416.
156. Geschwind D.H., Levitt P. Autism spectrum disorders: Developmental disconnection syndromes. Current Opinion in Neurobiology 2007, 17:103-111.
157. Gharani N., Benayed R., Mancuso V., Brzustowicz L.M., Millonig J.H. Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Molecular Psychiatry 2004, 9:474-484.
158. Gillberg C. Chromosomal disorders and autism. Journal of Autism and Developmental Disorders 1998, 28:415-425.
159. Gillberg C., Steffenburg S. Autistic behaviour in Moebius syndrome. Acta Paediatrica Scandinavica 1989, 78:314-316.
160. Gilman S.R., Iossifov I., Levy D., Ronemus M., Wigler M., Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011, 70:898-907.
161. Giulivi C., Zhang Y.F., Omanska-Klusek A., et al. Mitochondrial dysfunction in autism. Journal of the American Medical Association 2010, 304:2389-2396.
162. Glessner J.T., Wang K., Cai G., et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
163. Goffin A., Hoefsloot L.H., Bosgoed E., Swillen A., Fryns J.P. PTEN mutation in a family with Cowden syndrome and autism. American Journal of Medical Genetics 2001, 105:521-524.
164. Goffinet A.M. Events governing organization of postmigratory neurons: Studies on brain development in normal and reeler mice. Brain Research Reviews 1984, 7:261-296.
165. Gomot M., Belmonte M.K., Bullmore E.T., Bernard F.A., Baron-Cohen S. Brain hyper-reactivity to auditory novel targets in children with high-functioning autism. Brain 2008, 131:2479-2488.
166. Gong X., Bacchelli E., Blasi F., et al. Analysis of X chromosome inactivation in autism spectrum disorders. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2008, 147B:830-835.
167. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: Etymology and strategic intentions. The American Journal of Psychiatry 2003, 160:636-645.
168. Graf W., Marin-Garcia J., Gao H.G., et al. Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. Journal of Child Neurology 2000, 15:357-361.
169. Grayson D.R., Chen Y., Costa E., et al. The human reelin gene: Transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacology and Therapeutics 2006, 111:272-286.
170. Green L., Fein D., Modahl C., Feinstein C., Waterhouse L., Morris M. Oxytocin and autistic disorder: Alterations in peptide forms. Biological Psychiatry 2001, 50:609-613.
171. Gregory S.G., Connelly J.J., Towers A.J., et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Medicine 2009, 7:62.
172. Guilmatre A., Dubourg C., Mosca A.L., et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Archives of General Psychiatry 2009, 66:947-956.
173. Gurrieri F., Neri G. Defective oxytocin function: A clue to understanding the cause of autism?. BMC Medicine 2009, 7:63.
174. Hall H., Lawyer G., Sillén A., et al. Potential genetic variants in schizophrenia: A Bayesian analysis. World Journal of Biological Psychiatry 2007, 8:12-22.
175. Hallene K.L., Oby E., Lee B.J., et al. Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations. Neuroscience 2006, 142:267-283.
176. Hallmayer J., Cleveland S., Torres A., et al. Genetic heritability and shared environmental factors among twin pairs with autism. Archives of General Psychiatry 2011, 68:1095-1102.
177. Hameury L., Roux S., Barthélémy C., et al. Quantified multidimensional assessment of autism and other pervasive developmental disorders. Application for bioclinical research. European Child and Adolescent Psychiatry 1995, 4:123-135.
178. Hammond P., Hutton T.J., Allanson J.E., et al. 3D analysis of facial morphology. American Journal of Medical Genetics Part A 2004, 126A:339-348.
179. Hammond P., Forster-Gibson C., Chudley A.E., et al. Face-brain asymmetry in autism spectrum disorders. Molecular Psychiatry 2008, 13:614-623.
180. Harvey C.G., Menon S.D., Stachowiak B., et al. Sequence variants within exon 1 of MECP2 occur in females with mental retardation. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2007, 144B:355-360.
181. v1.4 channel activation. Proceedings of the National Academy of Science of the United States of America 2005, 102:7553-7558.
182. Hérault J., Petit E., Martineau J., et al. Serotonin and autism: Biochemical and molecular biology features. Psychiatry Research 1996, 65:33-43.
183. Herman G.E., Butter E., Enrile B., Pastore M., Prior T.W., Sommer A. Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. American Journal of Medical Genetics Part A 2007, 143:589-593.
184. Herman G.E., Henninger N., Ratliff-Schaub K., Pastore M., Fitzgerald S., McBride K.L. Genetic testing in autism: How much is enough?. Genetic in Medicine 2007, 9:268-273.
185. Hernandez N., Metzger A., Magné R., et al. Exploration of core features of a human face by healthy and autistic adults analyzed by visual scanning. Neuropsychologia 2009, 47:1004-1012.
186. Hertz-Picciotto I., Croen L.A., Hansen R., Jones C.R., van de Water J., Pessah I.N. The CHARGE study: An epidemiologic investigation of genetic and environmental factors contributing to autism. Environmental Health Perspectives 2006, 114:1119-1125.
187. Herz J., Chen Y. Reelin, lipoprotein receptors and synaptic plasticity. Nature Reviews Neuroscience 2006, 7:850-859.
188. Hiesberger T., Trommsdorff M., Howell B.W., et al. Direct binding of reelin to VLDL receptor and APOE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulated tau phosphorylation. Neuron 1999, 24:481-489.
189. Hogart A., Nagarajan R.P., Patzel K.A., Yasui D.H., Lasalle J.M. 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Human Molecular Genetics 2007, 16:691-703.
190. Hogart A., Leung K.N., Wang N.J., et al. Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. Journal of Medical Genetics 2009, 46:86-93.
191. Hong S.E., Shugart Y.Y., Huang D.T., et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with RELN mutations. Nature Genetics 2000, 26:93-96.
192. Hope C.I., Sharp D.M., Hemara-Wahanui A., et al. Clinical manifestations of a unique X-linked retinal disorder in a large New Zealand family with a novel mutation in CACNA1F, the gene responsible for CSNB2. Clinical and Experimental Ophthalmology 2005, 33:129-136.
193. Hou J., Seth P., Major E.O. JC virus can infect human immune and nervous system progenitor cells: Implications for pathogenesis. Advances in Experimental Medicine and Biology 2006, 577:266-273. Eureka.com/Landes Bioscience, Georgetown, TX. N. Ahsan (Ed.).
194. Howlin P., Magiati I., Charman T. Systematic review of early intensive behavioral interventions for children with autism. American Journal on Intellectual and Developmental Disabilities 2009, 114:23-41.
195. Huang C.H., Santangelo S.L. Autism and serotonin transporter gene polymorphisms: A systematic review and meta-analysis. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2008, 147B:903-913.
196. Hunter J.W., Mullen G.P., McManus J.R., et al. Neuroligin-deficient mutants of C. elegans have sensory processing deficits and are hypersensitive to oxidative stress and mercury toxicity. Disease Models & Mechanisms 2010, 3:366-376.
197. Hussman J.P. Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. Journal of Autism and Developmental Disorders 2001, 31:247-248.
198. Iafrate A.J., Feuk L., Rivera M.N., et al. Detection of large-scale variation in the human genome. Nature Genetics 2004, 36:949-951. See Database of Genomic Variants at, (accessed September 2011). http://projects.tcag.ca/variation/.
199. Ichtchenko K., Hata Y., Nguyen T., et al. Neuroligin 1: A splice site-specific ligand for beta-neurexins. Cell 1995, 81:435-443.
200. Ieraci A., Forni P.E., Ponzetto C. Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development. Proceedings of the National Academy of Science of the United States of America 2002, 99:15200-15205.
201. Ingram J.L., Peckhan S.M., Tisdale B., Rodier P.M. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicology and Teratology 2000, 22:319-324.
202. Ingram J.L., Stodgell C.J., Hyman S.L., Figlewicz D.A., Weitkamp L.R., Rodier P.M. Discovery of allelic variants of HOXA1 and HOXB1: Genetic susceptibility to autism spectrum disorders. Teratology 2000, 62:393-405.
203. Inoue H., Yamasue H., Tochigi M., et al. Association between the oxytocin receptor gene and amygdalar volume in healthy adults. Biological Psychiatry 2010, 68:1066-1072.
204. Ivarsson S.A., Bjerre I., Vegfors P., Ahlfors K. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 1990, 21:102-103.
205. Jackman C., Horn N.D., Molleston J.P., Sokol D.K. Gene associated with seizures, autism, and hepatomegaly in an Amish girl. Pediatric Neurology 2009, 40:310-313.
206. Jackson P.B., Boccuto L., Skinner C., et al. Further evidence that the rs1858830C variant in the promoter region of the MET gene is associated with autistic disorder. Autism Research 2009, 2:232-236.
207. Jacob S., Brune C.W., Carter C.S., Leventhal B.L., Lord C., Cook E.H. Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neuroscience Letters 2007, 417:6-9.
208. Jacquemont M.L., Sanlaville D., Redon R., et al. Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. Journal of Medical Genetics 2006, 43:843-849.
209. Jamain S., Quach H., Betancur C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genetics 2003, 34:27-29.
210. Jentsch T.J., Stein V., Weinreich F., Zdebik A.A. Molecular structure and physiological function of chloride channels. Physiological Reviews 2002, 82:503-568.
211. Jin D., Liu H.X., Hirai H., et al. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 2007, 446:41-45.
212. Judson M.C., Bergman M.Y., Campbell D.B., Eagleson K.L., Levitt P. Dynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrain. Journal of Comparative Neurology 2009, 513:511-531.
213. Judson M.C., Eagleson K.L., Wang L., Levitt P. Evidence of cell-nonautonomous changes in dendrite and dendritic spine morphology in the met-signaling-deficient mouse forebrain. Journal of Comparative Neurology 2010, 518:4463-4478.
214. Jyonouchi H., Geng L., Ruby A., Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: Their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 2005, 51:77-85.
215. Kaminsky E.B., Kaul V., Paschall J., et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genetic Medicine 2011, 13:777-784.
216. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943, 2:217-250.
217. 3H-serotonin uptake by platelets in infantile autism and developmental language disorder (including five pairs of twins). Journal of Autism and Developmental Disorders 1986, 16:69-76.
218. Kawatani M., Nakai A., Okuno T., et al. Detection of cytomegalovirus in preserved umbilical cord from a boy with autistic disorder. Pediatrics International 2010, 52:304-307.
219. Kelemenova S., Schmidtova E., Ficek A., Celec P., Kubranska A., Ostatnikova D. Polymorphisms of candidate genes in Slovak autistic patients. Psychiatric Genetics 2010, 20:137-139.
220. Kilic S.S., Aydin S., Kilic N., Erman F., Aydin S., Celik I. Serum arylesterase and paraoxonase activity in patients with chronic hepatitis. World Journal of Gastroenterology 2005, 11:7351-7354.
221. Kim S.J., Young L.J., Gonen D., et al. Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphism in autism. Molecular Psychiatry 2002, 7:503-507.
222. 2+ sensitivity of sodium channels. The Journal of Biological Chemistry 2004, 43:45004-45012.
223. Kim S.A., Kim J.H., Park M., Cho I.H., Yoo H.J. Association of GABRB3 polymorphisms with autism spectrum disorders in Korean trios. Neuropsychobiology 2006, 54:160-165.
224. Kim H.G., Kishikawa S., Higgins A.W., et al. Disruption of neurexin 1 associated with autism spectrum disorder. American Journal of Human Genetics 2008, 82:199-207.
225. Kirov G., Rujescu D., Ingason A., Collier D.A., O'Donovan M.C., Owen M.J. Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophrenia Bulletin 2009, 35:851-854.
226. Klin A., Jones W., Schultz R., Volkmar F., Cohen D. Visual fixation patterns during viewing of naturalistic social situations as predictors of social competence in individuals with autism. Archives of General Psychiatry 2002, 59:809-816.
227. Knowles W.A. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Advances in Experimental Medicine and Biology 2006, 577:19-45. Eureka.com/Landes Bioscience, Georgetown, TX. N. Ahsan (Ed.).
228. Kolozsi E., Mackenzie R.N., Roullet F.I., deCatanzaro D., Foster J.A. Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice. Neuroscience 2009, 163:1201-1210.
229. Krebs M.O., Betancur C., Leroy S., et al. Absence of association between a polymorphic GGC repeat in the 5' untranslated region of the reelin gene and autism. Molecular Psychiatry 2002, 7:801-804.
230. 2+ signaling. Current Opinion in Neurobiology 2007, 17:112-119.
231. Kuemerle B., Gulden F., Cherosky N., Williams E., Herrup K. Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development. The Journal of Neuroscience 1997, 17:7881-7889.
232. Kumar R.A., KaraMohamed S., Sudi J., et al. Recurrent 16p11.2 microdeletions in autism. Human Molecular Genetics 2008, 17:628-638.
233. Kurnit D.M., Layton W.M., Matthysse S. Genetics, chance, and morphogenesis. American Journal of Human Genetics 1987, 41:979-995.
234. Kwon C.H., Luikart B.W., Powell C.M., et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006, 50:377-388.
235. Lai C.S.L., Fisher S.E., Hurst J.A., Vargha-Khadem F., Monaco A.P. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001, 413:519-523.
236. Lainhart J.E., Piven J., Wzorek M., et al. Macrocephaly in children and adults with autism. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36:282-290.
237. Lainhart J.E., Bigler E.D., Bocian M., et al. Head circumference and height in autism: A study by the Collaborative Program of Excellence in Autism. American Journal of Medical Genetics Part A 2006, 140:2257-2274.
238. Lam C.W., Yeung W.L., Ko C.H., et al. Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. Journal of Medical Genetics 2000, 37:e41.
239. Landrigan P.J. What causes autism? Exploring the environmental contribution. Current Opinion in Pediatrics 2010, 22:219-225.
240. LaSalle J.M. The Odyssey of MeCP2 and parental imprinting. Epigenetics 2007, 2:5-10.
241. Laumonnier F., Bonnet-Brilhault F., Gomot M., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. American Journal of Human Genetics 2004, 74:552-557.
242. Laumonnier F., Roger S., Guérin P., et al. Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation. American Journal of Psychiatry 2006, 163:1622-1629.
243. Laurence J.A., Fatemi S.H. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 2005, 4:206-210.
244. Lawson-Yuen A., Saldivar J.S., Sommer S., Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. European Journal of Human Genetics 2008, 16:614-618.
245. Lerer E., Levi S., Salomon S., Darvasi A., Yirmiya N., Ebstein R.P. Association between the oxytocin receptor (OXTR) gene and autism: Relationship to Vineland Adaptive Behavior Scales and cognition. Molecular Psychiatry 2008, 13:980-988.
246. Lesch K.P., Bengel D., Heils A., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
247. Lesch K.P., Wolozin B.L., Murphy D.L., Riederer P. Primary structure of the human platelet serotonin (5-HT) uptake site: Identity with the brain 5-HT transporter. Journal of Neurochemistry 1993, 60:2319-2322.
248. Leventhal B.L., Cook E.H., Morford M., Ravitz A., Freedman D.X. Relationships of whole blood serotonin and plasma norepinephrine within families. Journal of Autism and Developmental Disorders 1990, 20:499-511.
249. Levitt P., Campbell D.B. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. The Journal of Clinical Investigation 2009, 119:747-754.
250. Levitt P., Eagleson K.L., Powell E.M. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends in Neuroscience 2004, 27:400-406.
251. Levy D., Ronemus M., Yamrom B., et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011, 70:886-897.
252. Li J., Tabor H.K., Nguyen L., et al. Lack of association between HoxA1 and HoxB1 gene variants and autism in 110 multiplex families. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2002, 114:24-30.
253. Li J., Nguyen L., Gleason C., et al. Lack of evidence for an association between WNT2 and RELN polimorphisms and autism. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2004, 126:51-57.
254. Li H., Yamagata T., Mori M., Yasuhara A., Momoi M.Y. Mutation analysis of methyl-CpG binding protein family genes in autistic patients. Brain Development 2005, 27:321-325.
255. Li J., Ashley J., Budnik V., Bhat M.A. Crucial role of Drosophila neurexin in proper active zone apposition to postsynaptic densities, synaptic growth, and synaptic transmission. Neuron 2007, 55:741-755.
256. Li H., Li Y., Shao J., et al. The association analysis of RELN and GRM8 genes with autistic spectrum disorder in Chinese Han population. American Journal of Medical Genetics part B Neuropsychiatric Genetics 2008, 147B:194-200.
257. Li X., Hu Z., He Y., et al. Association analysis of CNTNAP2 polymorphisms with autism in the Chinese Han population. Psychiatric Genetics 2010, 20:113-117.
258. Liang J.S., Shimojima K., Ohno K., et al. A newly recognised microdeletion syndrome of 2p15-16.1 manifesting moderate developmental delay, autistic behaviour, short stature, microcephaly, and dysmorphic features: A new patient with 3.2Mb deletion. Journal of Medical Genetics 2009, 46:645-647.
259. Libbey J.E., Sweeten T.L., McMahon W.M., Fujinami R.S. Autistic disorder and viral infections. Journal of Neurovirology 2005, 11:1-10.
260. Lintas C., Persico A.M. Reelin gene polymorphisms in autistic disorder. Reelin Glycoprotein, Biology, Structure and Roles in Health and Disease 2008, 385-400. Springer, New York. S.H. Fatemi (Ed.).
261. Lintas C., Persico A.M. Autistic phenotypes and genetic testing: State-of-the-art for the clinical geneticist. Journal of Medical Genetics 2009, 46:1-8.
262. Lintas C., Persico A.M. Neocortical RELN promoter methylation increases significantly after puberty. NeuroReport 2010, 21:114-118.
263. Lintas C., Sacco R., Garbett K., et al. Involvement of the PRKCB1 gene in autistic disorder: Significant genetic association and reduced neocortical gene expression. Molecular Psychiatry 2009, 14:705-718.
264. Lintas C., Altieri L., Lombardi F., Sacco R., Persico A.M. Association of autism with polyomavirus infection in postmortem brains. Journal of Neurovirology 2010, 16:141-149.
265. Liu W., Pappas G.D., Carter C.S. Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/-) reeler mice. Neurological Research 2005, 27:339-345.
266. Liu X.Q., Paterson A.D., Szatmari P. Genome-wide linkage analyses of quantitative and categorical autism subphenotypes. Biological Psychiatry 2008, 64:561-570. Autism Genome Project Consortium.
267. Liu X., Kawamura Y., Shimada T., et al. Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population. Journal of Human Genetics 2010, 55:137-141.
268. Lobo-Menendez F., Sossey-Alaoui K., Bell J.M., et al. Absence of MeCP2 mutations in patients from the South Carolina autism project. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2004, 117B:97-101.
269. Lockstone H.E., Harris L.W., Swatton J.E., Wayland M.T., Holland A.J., Bahn S. Gene expression profiling in the adult Down syndrome brain. Genomics 2007, 90:647-660.
270. Lonetti G., Angelucci A., Morando L., Boggio E.M., Giustetto M., Pizzorusso T. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biological Psychiatry 2010, 67:657-665.
271. López-Pisón J., Rubio-Rubio R., Ureña-Hornos T., et al. Diagnóstico retrospectivo de infección congénita por citomegalovirus en un caso clínico infantil. Revista de Neurologìa 2005, 40:733-736.
272. Lugli G., Krueger J.M., Davis J.M., Persico A.M., Keller F., Smalheiser N.R. Methodological factors influencing measurement and processing of plasma reelin in humans. BMC Biochemistry 2003, 4:9.
273. Ma X.M., Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nature Reviews Molecular and Cellular Biology 2009, 10:307-318.
274. Ma D.Q., Whitehead P.L., Menold M.M., et al. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. American Journal of Human Genetics 2005, 77:377-388.
275. Ma D.Q., Rabionet R., Konidari I., et al. Association and gene-gene interaction of SLC6A4 and ITGB3 in autism. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2010, 153:477-483.
276. MacKenzie A., Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proceedings of the National Academy of Science of the United States of America 1999, 96:15251-15255.
277. Maestrini E., Lai C., Marlow A., et al. Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. American Journal of Medical Genetics 1999, 88:492-496.
278. Maher B. Personal genomes: The case of the missing heritability. Nature 2008, 456:18-21.
279. Marazziti D., Muratori F., Cesari A., et al. Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry 2000, 33:165-168.
280. Mark M., Lufkin T., Vonesch J.L., et al. Two rhombomeres are altered in Hoxa-1 mutant mice. Development 1993, 119:319-338.
281. Markowitz P.I. Autism in a child with congenital cytomegalovirus infection. Journal of Autism and Developmental Disorders 1983, 13:249-253.
282. Markram K., Rinaldi T., La Mendola D., Sandi C., Markram H. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 2008, 33:901-912.
283. Marshall C.R., Noor A., Vincent J.B., et al. Structural variation of chromosomes in autism spectrum disorder. American Journal of Human Genetics 2008, 82:477-488.
284. Martin E.R., Menold M.M., Wolpert C.M., et al. Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder. American Journal of Medical Genetics 2000, 96:43-48.
285. Martineau J., Andersson F., Barthélémy C., Cottier J.P., Destrieux C. Atypical activation of the mirror neuron system during perception of hand motion in autism. Brain Research 2010, 1320:168-175.
286. Martini F., Iaccheri L., Lazzarin L., et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Research 1996, 56:4820-4825.
287. McBride P.A., Anderson G.M., Hertzig M.E., et al. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry 1998, 37:767-776.
288. McBride K.L., Varga E.A., Pastore M.T., et al. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Research 2010, 3:137-141.
289. McCauley J.L., Olson L.M., Delahanty R., et al. A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2004, 131B:51-59.
290. McGraw C.M., Samaco R.C., Zoghbi H.Y. Adult neural function requires MeCP2. Science 2011, 333:186.
291. Meda L., Baron P., Prat E., et al. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid. Journal of Neuroimmunology 1999, 93:45-52.
292. Mefford H.C., Muhle H., Ostertag P., et al. Genome-wide copy number variation in epilepsy: Novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genetics 2010, 6:e1000962.
293. Mei H., Cuccaro M.L., Martin E.R. Multifactor dimensionality reduction-phenomics: A novel method to capture genetic heterogeneity with use of phenotypic variables. American Journal of Human Genetics 2007, 81:1251-1261.
294. Melke J., Goubran Botros H., Chaste P., Betancur C., et al. Abnormal melatonin synthesis in autism spectrum disorders. Molecular Psychiatry 2008, 13:90-98.
295. Menold M.M., Shao Y., Wolpert C.M., et al. Association analysis of chromosome 15 gabaa receptor subunit genes in autistic disorder. Journal of Neurogenetics 2001, 15:245-259.
296. Merikangas A.K., Corvin A.P., Gallagher L. Copy-number variants in neurodevelopmental disorders: Promises and challenges. Trends in Genetics 2009, 25:536-544.
297. Miles J.H., Hadden L.L., Takahashi T.N., Hillman R.E. Head circumference is an independent clinical finding associated with autism. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2000, 95:339-350.
298. Miles J.H., Takahashi T.N., Hong J., et al. Development and validation of a measure of dysmorphology: Useful for autism subgroup classification. American Journal of Medical Genetics Part A 2008, 146A:1101-1116.
299. Millen K.J., Wurst W., Herrup K., Joyner A.L. Abnormal embryonic development and patterning of postnatal foliation in two mouse Engrailed-2 mutants. Development 1994, 120:695-706.
300. Millen K.J., Hui C.C., Joyner A.L. A role for En-2 and other murine homologues of Drosophila segment polarity genes in regulating positional information in the developing cerebellum. Development 1995, 121:3935-3945.
301. Miller M.T., Strömland K., Ventura L., Johansson M., Bandim J.M., Gillberg C. Autism with ophthalmologic malformations: The plot thickens. Transactions of the American Ophthalmological Society 2004, 102:107-120.
302. Miller M.T., Strömland K., Ventura L., Johansson M., Bandim J.M., Gillberg C. Autism associated with conditions characterized by developmental errors in early embryogenesis: A mini review. International Journal of Developmental Neuroscience 2005, 23:201-219.
303. Miller M.T., Ventura L., Strömland K. Thalidomide and misoprostol: Ophthalmologic manifestations and associations both expected and unexpected. Birth Defects Research. Part A Clinical and Molecular Teratology 2009, 85:667-676.
304. Miller D.T., Adam M.P., Aradhya S., et al. Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics 2010, 86:749-764.
305. Minkowski E. La schizophrénie. Psychopathologie des schizoïdes et des schizophrènes 1927, Payot, Paris. 1st edn.
306. 2+ channels to synaptic vesicle exocytosis. Nature 2003, 423:939-948.
307. Miyazaki K., Narita N., Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: Implication for pathogenesis of autism. International Journal of Developmental Neuroscience 2005, 23:287-297.
308. Modahl C., Green L., Fein D., et al. Plasma oxytocin levels in autistic children. Biological Psychiatry 1998, 43:270-277.
309. Moessner R., Marshall C.R., Sutcliffe J.S., et al. Contribution of SHANK3 mutations to autism spectrum disorder. American Journal of Human Genetics 2007, 81:1289-1297.
310. Moore S.J., Turnpenny P., Quinn A., et al. A clinical study of 57 children with fetal anticonvulsant syndromes. Journal of Medical Genetics 2000, 37:489-497.
311. Muhle R., Trentacoste S.V., Rapin I. The genetics of autism. Pediatrics 2004, 113:e472-e486.
312. Mulder E.J., Anderson G.M., Kema I.P., et al. Platelet serotonin levels in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution, and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43:491-499.
313. Munesue T., Yokoyama S., Nakamura K., et al. Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neuroscience Research 2010, 67:181-191.
314. Muscarella L.A., Guarnieri V., Sacco R., et al. HOXA1 gene variants influence head growth rates in humans. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2007, 144B:388-390.
315. Muscarella L.A., Guarnieri V., Sacco R., et al. Candidate gene study of HOXB1 in autism spectrum disorder. Molecular Autism 2010, 1:9.
316. Nakasato A., Nakatani Y., Seki Y., Tsujino N., Umino M., Arita H. Swim stress exaggerates the hyperactive mesocortical dopamine system in a rodent model of autism. Brain Research 2008, 1193:128-135.
317. Napolioni V., Lombardi F., Sacco R., et al. Family-based association study of ITGB3 in autism spectrum disorder and its endophenotypes. European Journal of Human Genetics 2011, 19:353-359.
318. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: Putative animal models for autism. Pediatric Research 2002, 52:576-579.
319. Neves-Pereira M., Müller B., Massie D., et al. Deregulation of EIF4E: A novel mechanism for autism. Journal of Medical Genetics 2009, 46:759-765.
320. Nissenkorn A., Zeharia A., Lev D., et al. Neurologic presentations of mitochondrial disorders. Journal of Child Neurology 2000, 15:44-48.
321. Nurmi E.L., Dowd M., Tadevosyan-Leyfer O., Haines J.L., Folstein S.E., Sutcliffe J.S. Exploratory subsetting of autism families based on savant skills improves evidence of genetic linkage to 15q11-q13. The Journal of the American Academy of Child and Adolescent Psychiatry 2003, 42:856-863.
322. O'Dushlaine C., Kenny E., Heron E., et al. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Molecular Psychiatry 2010, 16:286-292.
323. Okunishi K., Dohi M., Nakagome K., et al. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. The Journal of Immunology 2005, 175:4745-4753.
324. Orrico A., Galli L., Buoni S., Orsi A., Vonella G., Sorrentino V. Novel PTEN mutations in neurodevelopmental disorders and macrocephaly. Clinical Genetics 2009, 75:195-198.
325. Ozonoff S., Young G.S., Carter A., et al. Recurrence risk for autism spectrum disorders: A Baby Siblings Research Consortium Study. Pediatrics 2011, 128:e488-e495.
326. Page D.T., Kuti O.J., Prestia C., Sur M. Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior. Proceedings of the National Academy of Science of the United States of America 2009, 106:1989-1994.
327. Palmieri L., Persico A.M. Mitochondrial dysfunction in autism spectrum disorders: Cause or effect?. Biochimica et Biophysica Acta 2010, 1797:1130-1137.
328. Palmieri L., Papaleo V., Porcelli V., et al. Altered calcium homeostasis in autism-spectrum disorders: Evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Molecular Psychiatry 2010, 15:38-52.
329. Pampanos A., Volaki K., Kanavakis E., et al. A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population. Genetic Testing and Molecular Biomarkers 2009, 13:611-615.
330. Parnas J., Bovet P., Zahavi D. Schizophrenic autism: Clinical phenomenology and pathogenic implications. World Psychiatry 2002, 1:131-136.
331. Parra S., Alonso-Villaverde C., Coll B., et al. Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection. Atherosclerosis 2007, 194:175-181.
332. Persico A.M. Developmental roles of the serotonin transporter. Experimental Models in Serotonin Transporter Research 2009, 78-104. Cambridge University Press, Cambridge, UK. A.V. Kalueff (Ed.).
333. Persico A.M. Polyomaviruses and autism: More than simple association?. Journal of Neurovirology 2010, 16:332-333.
334. Persico A.M., Bourgeron T. Searching for ways out of the autism maze: Genetic, epigenetic and environmental clues. Trends in Neuroscience 2006, 29:349-358.
335. Persico A.M., Sacco R. Endophenotypes in Autism Spectrum Disorder. The Comprehensive Guide to Autism 2013, Springer Science + Business Media B.V., Dordrecht, Netherlands, in press. V.B. Patel, V.R. Preedy, C. Martin (Eds.).
336. Persico A.M., D'Agruma L., Maiorano N., et al. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Molecular Psychiatry 2001, 6:150-159.
337. Persico A.M., Pascucci T., Puglisi-Allegra S., et al. Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children. Molecular Psychiatry 2002, 7:795-800.
338. Persico A.M., Levitt P., Pimenta A. Polymorphic GGC repeat differentially regulates human reelin gene expression levels. Journal of Neural Transmission 2006, 113:1373-1382.
339. Petit E., Hérault J., Martineau J., et al. Association study with two markers of a human homeogene in infantile autism. Journal of Medical Genetics 1995, 32:269-274.
340. Petropoulos H., Friedman S.D., Shaw D.W., Artru A.A., Dawson G., Dager S.R. Gray matter abnormalities in autism spectrum disorder revealed by T2 relaxation. Neurology 2006, 67:632-636.
341. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. Journal of Biological Chemistry 2001, 276:36734-36741.
342. Pinto D., Pagnamenta A.T., Klei L., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
343. Piven J., Palmer P., Jacobi D., Childress D., Arndt S. Broader autism phenotype: Evidence from a family history study of multiple-incidence autism families. American Journal of Psychiatry 1997, 154:185-190.
344. Piven J., Tsai G., Nehme E., Coyle J.T., Chase G.A., Folstein S.E. Platelet serotonin, a possible marker for familial autism. Journal of Autism and Developmental Disorders 1991, 21:51-59.
345. Pons R., Andreu A.L., Checcarelli N., et al. Mitochondrial DNA abnormalities and autistic spectrum disorders. Journal of Pediatrics 2004, 144:81-85.
346. Poot M., Beyer V., Schwaab I., et al. Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 2010, 11:81-89.
347. Prasad H.C., Zhu C.B., McCauley J.L., et al. Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proceedings of the National Academy of Science of the United States of America 2005, 102:11545-11550.
348. Prasad H.C., Steiner J.A., Sutcliffe J.S., Blakely R.D. Enhanced activity of human serotonin transporter variants associated with autism. Philosophical Transactions of the Royal Society B: Biological Sciences 2009, 364:163-173.
349. Qin J., Jia M., Wang L., et al. Association study of SHANK3 gene polymorphisms with autism in Chinese Han population. BMC Medical Genetics 2009, 10:61.
350. Qiu S., Anderson C.T., Levitt P., Shepherd G.M. Circuit-specific intracortical hyperconnectivity in mice with deletion of the autism-associated Met receptor tyrosine kinase. The Journal of Neuroscience 2011, 31:5855-5864.
351. Quattrocchi C.C., Wannenes F., Persico A.M., et al. Reelin is a serine protease of the extracellular matrix. Journal of Biological Chemistry 2002, 277:303-309.
352. Radyushkin K., Hammerschmidt K., Boretius S., et al. Neuroligin-3-deficient mice: Model of a monogenic heritable form of autism with an olfactory deficit. Genes, Brain and Behavior 2009, 8:416-425.
353. Rajcan-Separovic E., Harvard C., Liu X., et al. Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1. Journal of Medical Genetics 2007, 44:269-276.
354. Rasalam A.D., Hailey H., Williams J.H., et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Developmental Medicine & Child Neurology 2005, 47:551-555.
355. Rauh V.A., Garfinkel R., Perera F.P., et al. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 2006, 118:e1845-e1859.
356. Reichelt K.L., Hole K., Hamberger A., et al. Biologically active peptide-containing fractions in schizophrenia and childhood autism. Advances in Biochemical Psychopharmacology 1981, 28:627-643.
357. Rekvig O.P., Bendiksen S., Moens U. Immunity and autoimmunity induced by polyomaviruses: Clinical, experimental and theoretical aspects. Advances in Experimental Medicine and Biology 2006, 577:117-147. Eureka.com/Landes Bioscience, Georgetown, TX. N. Ahsan (Ed.).
358. Rett A. Über ein zerebral-atrophisches Syndrom bei Hyperammonämie. Wiener medizinische Wochenschrift 1966, 116:723-726.
359. Rice D., Barone S. Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environmental Health Perspectives 2000, 108(supplement 3):511-533.
360. Rice D.S., Curran T. Role of the reelin signaling pathway in central nervous system development. Annual Review of Neuroscience 2001, 24:1005-1039.
361. Rinaldi T., Kulangara K., Antoniello K., Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proceedings of the National Academy of Science of the United States of America 2007, 104:13501-13506.
362. Rinaldi T., Silberberg G., Markram H. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cerebral Cortex 2008, 18:763-770.
363. Riva D., Giorgi C. The cerebellum contributes to higher functions during development: Evidence from a series of children surgically treated for posterior fossa tumours. Brain 2000, 123:1051-1061.
364. Roberts E.M., English P.B., Grether J.K., Windham G.C., Somberg L., Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environmental Health Perspectives 2007, 115:1482-1489.
365. Rodier P.M. Converging evidence for brain stem injury in autism. Developmental Psychopathology 2002, 14:537-557.
366. Rodier P.M., Ingram J.L., Tisdale B., Nelson S., Romano J. Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei. Journal of Comparative Neurology 1996, 370:247-261.
367. Rogers S.J., Vismara L.A. Evidence-based comprehensive treatments for early autism. Journal of Clinical Child Adolescent Psychology 2008, 37:8-38.
368. Romano V., Calì F., Mirisola M., et al. Lack of association of HOXA1 and HOXB1 mutations and autism in Sicilian (Italian) patients. Molecular Psychiatry 2003, 8:716-717.
369. Rossell M., Capecchi M.R. Mice mutant for both Hoxa1 and Hoxb1 show extensive remodeling of the hindbrain and defects in craniofacial development. Development 1999, 126:5027-5040.
370. Rossi E., Verri A.P., Patricelli M.G., et al. A 12Mb deletion at 7q33-q35 associated with autism spectrum disorders and primary amenorrhea. European Journal of Medical Genetics 2008, 51:631-638.
371. Rossignol D.A., Frye R.E. Mitochondrial dysfunction in autism spectrum disorders: A systematic review and meta-analysis. Molecular Psychiatry 2011, 69:41R-47R.
372. Rout U.K., Clausen P. Common increase of GATA-3 level in PC-12 cells by three teratogens causing autism spectrum disorders. Neuroscience Research 2009, 64:162-169.
373. Roux S., Bruneau N., Garreau B., et al. Bioclinical profiles of autism and other developmental disorders using a multivariate statistical approach. Biological Psychiatry 1997, 42:1148-1156.
374. Rubenstein J.L., Merzenich M.M. Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes, Brain and Behavior 2003, 2:255-267.
375. Rujescu D., Ingason A., Cichon S., et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Human Molecular Genetics 2009, 18:988-996.
376. Russo A.J., Krigsman A., Jepson B., Wakefield A. Decreased serum hepatocyte growth factor (HGF) in autistic children with severe gastrointestinal disease. Biomarker Insights 2009, 2:181-190.
377. Rutter M. Incidence of autism spectrum disorders: Changes over time and their meaning. Acta Paediatrica 2005, 94:2-15.
378. Rutter M., Kreppner J., Croft C., et al. Early adolescent outcomes of institutionally deprived and non-deprived adoptees III. Quasi-autism. Journal of Child Psychology and Psychiatry 2007, 48:1200-1207.
379. Sacco R., Militerni R., Frolli A., et al. Clinical, morphological, and biochemical correlates of head circumference in autism. Biological Psychiatry 2007, 62:1038-1047.
380. Sacco R., Papaleo V., Hager J., et al. Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes: TPH2 and GLO1. BMC Medical Genetics 2007, 8:11.
381. Sacco R., Curatolo P., Manzi B., et al. Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. Autism Research 2011, 3:237-252.
382. Sacco R., Persico A.M., Garbett K.A., Mirnics K. Genome-wide expression studies in autism-spectrum disorders: Moving from neurodevelopment to neuroimmunology. Advances in Neurobiology 2 - Genomics, Proteomics, and the Nervous System 2011, 469-487. Springer, New York. J.D. Clelland (Ed.).
383. Sakurai T., Ramoz N., Reichert J.G., et al. Association analysis of the NrCAM gene in autism and in subsets of families with severe obsessive-compulsive or self-stimulatory behaviors. Psychiatric Genetics 2006, 16:251-257.
384. Salmon B., Hallmayer J., Rogers T., et al. Absence of linkage and linkage disequilibrium to chromosome 15q11-q13 markers in 139 multiplex families with autism. American Journal of Medical Genetics 1999, 88:551-556.
385. Samaco R.C., Hogart A., LaSalle J.M. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Human Molecular Genetics 2005, 14:483-492.
386. Sanders S.J., Ercan-Sencicek A.G., Hus V., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
387. Saresella M., Marventano I., Guerini F.R., et al. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biological Psychiatry 2009, 66:978-984.
388. Schaaf C.P., Zoghbi H.Y. Solving the autism puzzle a few pieces at a time. Neuron 2011, 70:806-808.
389. Schaaf C.P., Sabo A., Sakai Y., et al. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Human Molecular Genetics 2011, 20:3366-3375.
390. Schaefer G.B., Mendelson N.J. Genetic evaluation for the etiologic diagnosis of autism spectrum disorders. Genetics in Medicine 2008, 10:4-12.
391. Schanen N.C. Epigenetics of autism spectrum disorders. Human Molecular Genetics 2006, 15(Spec No 2):R138-R150.
392. Scheiffele P., Fan J., Choih J., Fetter R., Serafini T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 2000, 101:657-669.
393. Schneider T., Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism. Neuropsychopharmacology 2005, 30:80-89.
394. Schneider T., Labuz D., Przewłocki R. Nociceptive changes in rats after prenatal exposure to valproic acid. Polish Journal of Pharmacology 2001, 53:531-534.
395. Schneider T., Turczak J., Przewłocki R. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: Issues for a therapeutic approach in autism. Neuropsychopharmacology 2006, 31:36-46.
396. Schneider T., Ziòłkowska B., Gieryk A., Tyminska A., Przewłocki R. Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism. Psychopharmacology (Berl) 2007, 193:547-555.
397. Schroer R.J., Phelan M.C., Michaelis R.C., et al. Autism and maternally derived aberrations of chromosome 15q. American Journal of Medical Genetics 1998, 76:327-336.
398. Scott-Van Zeeland A.A., Abrahams B.S., Alvarez-Retuerto A.I., et al. Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Science Translational Medicine 2010, 2:56ra80.
399. Sebat J., Lakshmi B., Malhotra D., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
400. Sen B., Sinha S., Ahmed S., Ghosh S., Gangopadhyay P.K., Usha R. Lack of association of HOXA1 and HOXB1 variants with autism in the Indian population. Psychiatric Genetics 2007, 17:1.
401. Sen B., Singh A.S., Sinha S., et al. Family-based studies indicate association of Engrailed 2 gene with autism in an Indian population. Genes Brain & Behavior 2010, 9:248-255.
402. Serajee F.J., Zhong H., Huq A.H. Association of reelin gene polymorphisms with autism. Genomics 2006, 87:75-83.
403. Shadel G. Expression and maintenance of mitochondrial DNA: New insights into human disease pathology. American Journal of Pathology 2008, 172:1445-1456.
404. Shao Y., Cuccaro M.L., Hauser E.R., et al. Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes. American Journal of Human Genetics 2003, 72:539-548.
405. Shibayama A., Cook E.H., Feng J., et al. MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2004, 128B:50-53.
406. Shifman S., Johannesson M., Bronstein M., et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genetics 2008, 4:e28.
407. Shoffner J., Hyams L., Langley G.N., et al. Fever plus mitochondrial disease could be risk factors for autistic regression. Journal of Child Neurology 2010, 25:429-434.
408. Skaar D.A., Shao Y., Haines J.L., et al. Analysis of the RELN gene as a genetic risk factor for autism. Molecular Psychiatry 2005, 10:563-571.
409. Smith M., Spence M.A., Flodman P. Nuclear and mitochondrial genome defects in autisms. Annals of the New York Academy of Science 2009, 1151:102-132.
410. Snow W.M., Hartle K., Ivanco T.L. Altered morphology of motor cortex neurons in the VPA rat model of autism. Developmental Psychobiology 2008, 50:633-639.
411. Sousa I., Clark T.G., Toma C., et al. MET and autism susceptibility: Family and case-control studies. European Journal of Human Genetics 2009, 17:749-758.
412. Spence S.J., Cantor R.M., Chung L., Kim S., Geschwind D.H., Alarcón M. Stratification based on language related endophenotypes in autism: Attempt to replicate reported linkage. American Journal of Medical Genetics, Part B Neuropsychiatric Genetics 2006, 141B:591-598.
413. V1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31.
414. Splawski I., Yoo D.S., Stotz S.C., Cherry A., Clapham D.E., Keating M.T. CACNA1H mutations in autism spectrum disorders. The Journal of Biological Chemistry 2006, 281:22085-22091.
415. Stevenson R.E., Schroer R.J., Skinner C., Fender D., Simensen R.J. Autism and macrocephaly. Lancet 1997, 349:1744-1745.
416. Stodgell C.J., Ingram J.L., O'Bara M., Tisdale B.K., Nau H., Rodier P.M. Induction of the homeotic gene Hoxa1 through valproic acid's teratogenic mechanism of action. Neurotoxicology and Teratology 2006, 28:617-624.
417. Stone J.L., Merriman B., Cantor R.M., et al. Evidence for sex-specific risk alleles in autism spectrum disorder. American Journal of Human Genetics 2004, 75:1117-1123.
418. Strömland K., Nordin V., Miller M., Akerström B., Gillberg C. Autism in thalidomide embryopathy: A population study. Developmental Medicine and Child Neurology 1994, 36:351-356.
419. Stubbs E.G. Autistic symptoms in a child with congenital cytomegalovirus infection. Journal of Autism and Childhood Schizophrenia 1978, 8:37-43.
420. Stubbs E.G., Ash E., Williams C.P. Autism and congenital cytomegalovirus. Journal of Autism and Developmental Disorders 1984, 14:183-189.
421. Südhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
422. Sugihara G., Hashimoto K., Iwata Y., et al. Decreased serum levels of hepatocyte growth factor in male adults with high-functioning autism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007, 31:412-415.
423. Sun L., Huang L., Nguyen P., et al. DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation. Cancer Research 2008, 68:2726-2735.
424. Sutcliffe J.S., Delahanty R.J., Prasad H.C., et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. American Journal of Human Genetics 2005, 77:265-279.
425. Sweeten T.L., Posey D.J., McDougle C.J. Brief report: Autistic disorder in three children with cytomegalovirus infection. Journal of Autism and Developmental Disorders 2004, 34:583-586.
426. Sykes N.H., Toma C., Wilson N., et al. Copy number variation and association analysis of SHANK3 as a candidate gene for autism in the IMGSAC collection. European Journal of Human Genetics 2009, 17:1347-1353.
427. Tabuchi K., Blundell J., Etherton M.R., et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
428. Takayanagi Y., Yoshida M., Bielsky I.F., et al. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proceedings of the National Academy of Science of the United States of America 2005, 102:16096-16101.
429. Talebizadeh Z., Bittel D.C., Miles J.H., et al. No association between HOXA1 and HOXB1 genes and autism spectrum disorders (ASD). Journal of Medical Genetics 2002, 39:e70.
430. Tan G.C., Doke T.F., Ashburner J., Wood N.W., Frackowiak R.S. Normal variation in fronto-occipital circuitry and cerebellar structure with an autism-associated polymorphism of CNTNAP2. Neuroimage 2010, 53:1030-1042.
431. Tansey K.E., Brookes K.J., Hill M.J., et al. Oxytocin receptor (OXTR) does not play a major role in the aetiology of autism: Genetic and molecular studies. Neuroscience Letters 2010, 474:163-167.
432. Teitelbaum O., Benton T., Shah P.K., Prince A., Kelly J.L., Teitelbaum P. Eshkol-Wachman movement notation in diagnosis: The early detection of Asperger's syndrome. Proceedings of the National Academy of Science of the United States of America 2004, 101:11909-11914.
433. Thompson E.E., Pan L., Ostrovnaya I., et al. Integrin beta 3 genotype influences asthma and allergy phenotypes in the first 6 years of life. Journal of Allergy and Clinical Immunology 2007, 119:1423-1429.
434. Tischfield M.A., Bosley T.M., Salih M.A., et al. Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development. Nature Genetics 2005, 37:1035-1037.
435. Tochigi M., Kato C., Koishi S., et al. No evidence for significant association between GABA receptor genes in chromosome 15q11-q13 and autism in a Japanese population. Journal of Human Genetics 2007, 52:985-989.
436. Tost H., Lipska B.K., Vakkalanka R., et al. No effect of a common allelic variant in the reelin gene on intermediate phenotype measures of brain structure, brain function, and gene expression. Biological Psychiatry 2010, 68:105-107.
437. Tripathi P.P., Sgadò P., Scali M., et al. Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice. Neuroscience 2009, 159:842-849.
438. Tripi G., Roux S., Canziani T., Bonnet Brilhault F., Barthélémy C., Canziani F. Minor physical anomalies in children with autism spectrum disorder. Early Human Development 2008, 84:217-223.
439. Tropea D., Giacometti E., Wilson N.R., et al. Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proceedings of the National Academy of Science of the United States of America 2009, 106:2029-2034.
440. Tsujino N., Nakatani Y., Seki Y., et al. Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism. Neuroscience Research 2007, 57:289-295.
441. Tuchman R., Rapin I. Epilepsy in autism. Lancet Neurology 2002, 1:352-358.
442. Turner L.M., Stone W.L. Variability in outcome for children with an ASD diagnosis at age 2. Journal of Child Psychology and Psychiatry 2007, 48:793-802.
443. van Daalen E., Swinkels S.H., Dietz C., van Engeland H., Buitelaar J.K. Body length and head growth in the first year of life in autism. Pediatric Neurology 2007, 37:324-330.
444. van Daalen E., Kemner C., Dietz C., Swinkels S.H., Buitelaar J.K., van Engeland H. Inter-rater reliability and stability of diagnoses of autism spectrum disorder in children identified through screening at a very young age. European Child & Adolescent Psychiatry 2009, 18:663-674.
445. van den Pol A.N. Viral infections in the developing and mature brain. Trends in Neurosciences 2006, 29:398-406.
446. Van Lenten B.J., Wagner A.C., Nayak D.P., Hama S., Navab M., Fogelman A.M. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation 2001, 103:2283-2288.
447. Van Lenten B.J., Wagner A.C., Anantharamaiah G.M., et al. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation 2002, 106:1127-1132.
448. Vancassel S., Durand G., Barthélémy C., et al. Plasma fatty acid levels in autistic children. Prostaglandins, Leukotrienes and Essential Fatty Acids 2001, 65:1-7.
449. Varga E.A., Pastore M., Prior T., Herman G.E., McBride K.L. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genetics in Medicine 2009, 11:111-117.
450. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology 2005, 57:67-81.
451. Varoqueaux F., Aramuni G., Rawson R.L., et al. Neuroligins determine synapse maturation and function. Neuron 2006, 51:741-754.
452. Veenstra-Vanderweele J., Jessen T.N., Thompson B.J., et al. Modeling rare gene variation to gain insight into the oldest biomarker in autism: Construction of the serotonin transporter Gly56Ala knock-in mouse. Journal of Neurodevelopmental Disorders 2009, 1:158-171.
453. Vernes S.C., Newbury D.F., Abrahams B.S., et al. A functional genetic link between distinct developmental language disorders. The New England Journal of Medicine 2008, 359:2337-2345.
454. Vorstman J.A., van Daalen E., Jalali G.R., et al. A double hit implicates DIAPH3 as an autism risk gene. Molecular Psychiatry 2010, 16:442-451.
455. Vourc'h P., Bienvenu T., Beldjord C., et al. No mutations in the coding region of the Rett syndrome gene MECP2 in 59 autistic patients. European Journal of Human Genetics 2001, 9:556-558.
456. Wallace G.L., Happé F., Giedd J.N. A case study of a multiply talented savant with an autism spectrum disorder: Neuropsychological functioning and brain morphometry. Philosophical Transactions of the Royal Society B: Biological Sciences 2009, 364:1425-1432.
457. Wang L., Jia M., Yue W., et al. Association of the ENGRAILED 2 (EN2) gene with autism in Chinese Han population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2008, 147B:434-438.
458. Wassink T.H., Piven J., Vieland V.J., et al. Examination of AVPR1a as an autism susceptibility gene. Molecular Psychiatry 2004, 9:968-972.
459. Weiss L.A. Autism genetics: Emerging data from genome-wide copy-number and single nucleotide polymorphism scans. Expert Review of Molecular Diagnostics 2009, 9:795-803.
460. Weiss L.A., Escayg A., Kearney J.A., et al. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Molecular Psychiatry 2003, 8:186-194.
461. Weiss L.A., Veenstra-Vanderweele J., Newman D.L., et al. Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin. European Journal of Human Genetics 2004, 12:949-954.
462. Weiss L.A., Abney M., Cook E.H., Ober C. Sex-specific genetic architecture of whole blood serotonin levels. American Journal of Human Genetics 2005, 76:33-41.
463. Weiss L.A., Abney M., Parry R., Scanu A.M., Cook E.H., Ober C. Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample. Human Genetics 2005, 117:81-87.
464. Weiss L.A., Lester L.A., Lester L.A., et al. Variation in ITGB3 is associated with asthma and sensitization to mold allergen in four populations. American Journal of Respiratory and Critical Care Medicine 2005, 172:67-73.
465. Weiss L.A., Ober C., Cook E.H. ITGB3 shows genetic and expression interaction with SLC6A4. Human Genetics 2006, 120:93-100.
466. Weiss L.A., Kosova G., Delahanty R.J., et al. Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. European Journal Human Genetics 2006, 14:923-931.
467. Weiss L.A., Shen Y., Korn J.M., et al. Association between microdeletion and microduplication at 16p11.2 and autism. New England Journal of Medicine 2008, 358:667-675.
468. Weissman J.R., Kelley R.I., Bauman M.L., et al. Mitochondrial disease in autism spectrum disorder patients: A cohort analysis. PLoS One 2008, 3:e3815.
469. Wermter A.K., Kamp-Becker I., Hesse P., Schulte-Körne G., Strauch K., Remschmidt H. Evidence for the involvement of genetic variation in the oxytocin receptor gene (OXTR) in the etiology of autistic disorders on high-functioning level. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2010, 153B:629-639.
470. Whyatt R.M., Barr D.B. Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: A validation study. Environmental Health Perspectives 2001, 109:417-420.
471. Whyatt R.M., Barr D.B., Camann D.E., et al. Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. Environmental Health Perspectives 2003, 111:749-756.
472. Williams P.G., Hersh J.H. A male with fetal valproate syndrome and autism. Developmental Medicine & Child Neurology 1997, 39:632-634.
473. Williams G., King J., Cunningham M., Stephan M., Kerr B., Hersh J.H. Fetal valproate syndrome and autism: Additional evidence of an association. Developmental Medicine & Child Neurology 2001, 43:202-206.
474. Wiltse J. Mode of action: Inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin-developmental effects of valproic acid. Critical Reviews in Toxicology 2005, 35:727-738.
475. Windham G.C., Zhang L., Gunier R., Croen L.A., Grether J.K. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the san francisco bay area. Environmental Health Perspectives 2006, 114:1438-1444.
476. Wing L. Asperger's Syndrome: A clinical account. Psychological Medicine 1981, 11:115-130.
477. Wolf U. Identical mutations and phenotypic variation. Human Genetics 1997, 100:305-321.
478. Woodhouse W., Bailey A., Rutter M., Bolton P., Baird G., Le Couteur A. Head circumference in autism and other pervasive developmental disorders. Journal of Child Psychology and Psychiatry 1996, 37:665-671.
479. Wu S., Jia M., Ruan Y., et al. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biological Psychiatry 2005, 58:74-77.
480. Xi C.Y., Ma H.W., Lu Y., et al. MeCP2 gene mutation analysis in autistic boys with developmental regression. Psychiatric Genetics 2007, 17:113-116.
481. Yamashita Y., Fujimoto C., Nakajima E., Isagai T., Matsuishi T. Possible association between congenital cytomegalovirus infection and autistic disorder. Journal of Autism and Developmental Disorders 2003, 33:455-459.
482. Yan J., Oliveira G., Coutinho A., et al. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Molecular Psychiatry 2005, 10:329-332.
483. Yan J., Feng J., Schroer R., et al. Analysis of the neuroligin 4Y gene in patients with autism. Psychiatric Genetics 2008, 18:204-207.
484. Yan J., Noltner K., Feng J., et al. Neurexin 1alpha structural variants associated with autism. Neuroscience Letters 2008, 438:368-370.
485. Yang P., Lung F.W., Jong Y.J., Hsieh H.Y., Liang C.L., Juo S.H. Association of the homeobox transcription factor gene ENGRAILED 2 with autistic disorder in Chinese children. Neuropsychobiology 2008, 57:3-8.
486. Yang P., Shu B.C., Hallmayer J.F., Lung F.W. Intronic single nucleotide polymorphisms of engrailed homeobox 2 modulate the disease vulnerability of autism in a Han Chinese population. Neuropsychobiology 2010, 62:104-115.
487. Yirmiya N., Rosenberg C., Levi S., et al. Association between arginine vasopressin receptor 1A (AVPR1a) gene and autism in a family-based study: Mediation by social skills. Molecular Psychiatry 2006, 11:488-494.
488. Yoo H.K., Chung S., Hong J.P., Kim B.N., Cho S.C. Microsatellite marker in gamma-aminobutyric acid-a receptor beta 3 subunit gene and autism spectrum disorders in Korean trios. Yonsei Medical Journal 2009, 50:304-306.
489. Young D.J., Bebbington A., Anderson A., et al. The diagnosis of autism in a female: Could it be Rett syndrome?. European Journal of Pediatrics 2008, 167:661-669.
490. Yrigollen C.M., Han S.S., Kochetkova A., et al. Genes controlling affiliative behavior as candidate genes for autism. Biological Psychiatry 2008, 63:911-916.
491. Zafeiriou D.I., Ververi A., Vargiami E. Childhood autism and associated comorbidities. Brain and Development 2007, 29:257-272.
492. Zappella M., Meloni I., Longo I., et al. Study of MECP2 gene in Rett syndrome variants and autistic girls. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2003, 119B:102-107.
493. Zeng X., Sun M., Liu L., Chen F., Wei L., Xie W. Neurexin-1 is required for synapse formation and larvae associative learning in Drosophila. FEBS Letters 2007, 581:2509-2516.
494. Zeviani M., Di Donato S. Mitochondrial disorders. Brain 2004, 127:2153-2172.
495. Zhang J., Smith K.R. Indoor air pollution: A global health concern. British Medical Bulletin 2003, 68:209-225.
496. Zhang H., Liu X., Zhang C., et al. Reelin gene alleles and susceptibility to autism spectrum disorders. Molecular Psychiatry 2002, 7:1012-1017.
497. 2+ channels. The Journal of Neuroscience 2005, 25:4330-4342.
498. Zhong H., Serajee F.J., Nabi R., Huq A.H. No association between the EN2 gene and autistic disorder. Journal of Medical Genetics 2003, 40:e4.
499. Zhou J., Blundell J., Ogawa S., et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. The Journal of Neuroscience 2009, 29:1773-1783.
500. Zhu C.B., Blakely R.D., Hewlett W.A. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006, 31:2121-2131.
501. Zweier C., de Jong E.K., Zweier M., et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. American Journal of Human Genetics 2009, 85:655-666.